Small molecule designv1.0.5

Pharmaceutical researchers use REINVENT4 to generate novel small molecules for emerging biological targets without known crystal structures, enabling rapid hit identification.

Medicinal chemists leverage PocketXMol to design molecules directly inside a protein binding pocket, guided by docking box from Get Box, and validate with Gnina Score for improved potency.

Biotech companies employ fragment linking via PocketXMol to connect weakly binding fragments into high-affinity leads, using Get Box to define the binding site.

AI researchers use REINVENT4's staged learning to optimize molecule properties (e.g., solubility, selectivity) through reinforcement learning with custom objectives.

University labs utilize Get Box to quickly calculate docking box coordinates from PDB IDs or descriptions, enabling structure-based drug design education and research.

SciMiner provides a subscription-based API for small-molecule design tools, charging per task or monthly fee for access to REINVENT4, PocketXMol, Get Box, and Gnina Score.

Offering a unified platform that combines structure-free and structure-based design with validation, sold to pharma companies as a SaaS solution for early-stage drug discovery.

Small-molecule design skill is offered as an add-on service for CROs, enabling them to provide AI-driven molecule generation and optimization to their clients.